Primary Objective:
Null hypothesis: A 24-week trial of adjunctive Lacosamide does not produce a decline in
cognitive, mood or quality of life measures.
To determine the cognitive and behavioral side effects of lacosamide in patients with partial
epilepsy and follow them for a period of 24 weeks using a neuropsychological test battery
drawing on tests commonly used and designed to maximize sensitivity to drug effects.
Secondary Objectives:
To determine if any significant changes in cognitive, mood or quality of life measures are
dependent upon changes in seizure severity, neurotoxicity, adverse events, or Lacosamide
dosage.